Eisai Co., Ltd. (TYO:4523)

Japan · Delayed Price · Currency is JPY

5,114.00

+14.00 (0.27%)

At close: Feb 20, 2026

Eisai Employees

Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.

Employees

10,917

Change (1Y)

-150

Growth (1Y)

-1.36%

Revenue / Employee

74.03M JPY

Profits / Employee

3.92M JPY

Market Cap

1.44T

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2025	10,917	-150	-1.36%
Mar 31, 2024	11,067	-9	-0.08%
Mar 31, 2023	11,076	-246	-2.17%
Mar 31, 2022	11,322	85	0.76%
Mar 31, 2021	11,237	239	2.17%
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
Takeda Pharmaceutical Company	47,455
Toho Holdings	7,609
Shionogi &	4,955
Towa Pharmaceutical	4,788
Tsumura & Co.	4,272
Sumitomo Pharma	3,832
Sawai Group Holdings	3,310
Hisamitsu Pharmaceutical Co.	2,799

Employee Rankings

Eisai News

10 days ago - Q3 2026 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
12 days ago - Eisai Co., Ltd. (ESAIY) Q3 2026 Earnings Call Transcript - Seeking Alpha
13 days ago - Eisai GAAP EPS of ¥148.31, revenue of ¥619.95B; reaffirms FY outlook - Seeking Alpha
13 days ago - Eisai Co., Ltd. 2026 Q3 - Results - Earnings Call Presentation - Seeking Alpha
15 days ago - Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump - Benzinga
16 days ago - Fosun Pharma’s US$1.55 billion Eisai deal signals shift to long-term partnerships - South China Morning Post
17 days ago - Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan - PRNewsWire
17 days ago - Eisai strikes Japan licensing deal with Shanghai Henlius Biotech - Reuters